237 related articles for article (PubMed ID: 33599984)
1. Women's satisfaction with and ongoing use of hormonal long-acting methods compared to the oral contraceptive pill: Findings from an Australian general practice cluster randomised trial (ACCORd).
Black KI; McGeechan K; Watson CJ; Lucke J; Taft A; McNamee K; Haas M; Peipert JF; Mazza D
Aust N Z J Obstet Gynaecol; 2021 Jun; 61(3):448-453. PubMed ID: 33599984
[TBL] [Abstract][Full Text] [Related]
2. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
Modesto W; Bahamondes MV; Bahamondes L
Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
[TBL] [Abstract][Full Text] [Related]
3. A multicentre, open-label, randomised phase III study comparing a new levonorgestrel intrauterine contraceptive system (LNG-IUS 8) with combined oral contraception in young women of reproductive age.
Borgatta L; Buhling KJ; Rybowski S; Roth K; Rosen K
Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):372-9. PubMed ID: 27494570
[TBL] [Abstract][Full Text] [Related]
4. The levonorgestrel intrauterine system: cohort study to assess satisfaction in a postpartum population in Kenya.
Hubacher D; Masaba R; Manduku CK; Chen M; Veena V
Contraception; 2015 Apr; 91(4):295-300. PubMed ID: 25601351
[TBL] [Abstract][Full Text] [Related]
5. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
[TBL] [Abstract][Full Text] [Related]
6. A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant.
Apter D; Briggs P; Tuppurainen M; Grunert J; Lukkari-Lax E; Rybowski S; Gemzell-Danielsson K
Fertil Steril; 2016 Jul; 106(1):151-157.e5. PubMed ID: 27016644
[TBL] [Abstract][Full Text] [Related]
7. Experiences with the levonorgestrel-releasing intrauterine system in Kenya: qualitative interviews with users and their partners.
Nanda G; Rademacher K; Solomon M; Mercer S; Wawire J; Ngahu R
Eur J Contracept Reprod Health Care; 2018 Aug; 23(4):303-308. PubMed ID: 30198796
[TBL] [Abstract][Full Text] [Related]
8. The use of different doses levonorgestrel-releasing intrauterine system (LNG-IUS): real-world data from a multicenter Italian study.
Bastianelli C; Farris M; Rosato E; Varliero F; Del Savio MC; Facchinetti F; Grandi G
Eur J Contracept Reprod Health Care; 2022 Feb; 27(1):16-22. PubMed ID: 34528867
[TBL] [Abstract][Full Text] [Related]
9. Three-year continuation of reversible contraception.
Diedrich JT; Zhao Q; Madden T; Secura GM; Peipert JF
Am J Obstet Gynecol; 2015 Nov; 213(5):662.e1-8. PubMed ID: 26259905
[TBL] [Abstract][Full Text] [Related]
10. Use of 52-mg Levonorgestrel-Releasing Intrauterine System in Adolescents and Young Adult Women: 3-Year Follow-Up.
Oliveira ECF; Baêta T; Cotta RCF; Rocha ALL
J Pediatr Adolesc Gynecol; 2023 Feb; 36(1):45-50. PubMed ID: 36089114
[TBL] [Abstract][Full Text] [Related]
11. Continuation and satisfaction of reversible contraception.
Peipert JF; Zhao Q; Allsworth JE; Petrosky E; Madden T; Eisenberg D; Secura G
Obstet Gynecol; 2011 May; 117(5):1105-1113. PubMed ID: 21508749
[TBL] [Abstract][Full Text] [Related]
12. Twenty-four-month continuation of reversible contraception.
O'Neil-Callahan M; Peipert JF; Zhao Q; Madden T; Secura G
Obstet Gynecol; 2013 Nov; 122(5):1083-1091. PubMed ID: 24104781
[TBL] [Abstract][Full Text] [Related]
13. Hormonally impregnated intrauterine systems (IUSs), versus other forms of reversible contraceptives as effective methods of preventing pregnancy.
French R; Cowan F; Mansour D; Morris S; Hughes D; Robinson A; Proctor T; Summerbell C; Logan S; Guillebaud J
Cochrane Database Syst Rev; 2001; (2):CD001776. PubMed ID: 11406007
[TBL] [Abstract][Full Text] [Related]
14. Changes in body composition in women using long-acting reversible contraception.
Silva Dos Santos PN; Madden T; Omvig K; Peipert JF
Contraception; 2017 Apr; 95(4):382-389. PubMed ID: 28041992
[TBL] [Abstract][Full Text] [Related]
15. Increasing long-acting reversible contraceptives: the Australian Contraceptive ChOice pRoject (ACCORd) cluster randomized trial.
Mazza D; Watson CJ; Taft A; Lucke J; McGeechan K; Haas M; McNamee K; Peipert JF; Black KI
Am J Obstet Gynecol; 2020 Apr; 222(4S):S921.e1-S921.e13. PubMed ID: 31837291
[TBL] [Abstract][Full Text] [Related]
16. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
17. Association of short-term bleeding and cramping patterns with long-acting reversible contraceptive method satisfaction.
Diedrich JT; Desai S; Zhao Q; Secura G; Madden T; Peipert JF
Am J Obstet Gynecol; 2015 Jan; 212(1):50.e1-8. PubMed ID: 25046805
[TBL] [Abstract][Full Text] [Related]
18. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
[TBL] [Abstract][Full Text] [Related]
19. Expanding long-acting contraceptive options: a prospective cohort study of the hormonal intrauterine device, copper intrauterine device, and implants in Nigeria and Zambia.
Brunie A; Stankevitz K; Nwala AA; Nqumayo M; Chen M; Danna K; Afolabi K; Rademacher KH
Lancet Glob Health; 2021 Oct; 9(10):e1431-e1441. PubMed ID: 34474001
[TBL] [Abstract][Full Text] [Related]
20. Increasing the uptake of long-acting reversible contraception in general practice: the Australian Contraceptive ChOice pRoject (ACCORd) cluster randomised controlled trial protocol.
Mazza D; Black K; Taft A; Lucke J; McGeechan K; Haas M; McKay H; Peipert JF
BMJ Open; 2016 Oct; 6(10):e012491. PubMed ID: 27855100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
